Insurance By Bob Herman Many Blue Cross Blue Shield plans aren’t paying taxes — and instead are swimming in refunds
Biotech By Allison DeAngelis Biospring Partners closes $245 million first fund as private markets tense up
Health Tech By Mohana Ravindranath Carbon Health, citing concerns about path to profitability, lays off 250 employees
Hospitals By Tara Bannow and Bob Herman Proton cancer centers continue to proliferate, despite shaky benefits and checkered financiers
Biotech By Allison DeAngelis With cryptocurrency and NFTs, ‘decentralized science’ seeks to upend drug industry financing
The Readout LOUD By Adam Feuerstein, Meg Tirrell and Damian Garde A longtime investor talks interest rates, biotech, and why luxury cars are a warning sign
A STAT Investigation By Casey Ross How a complex web of businesses turned private health records from GE into a lucrative portrait of patients
Biotech By Allison DeAngelis Apollo acquires minority stake in Sofinnova, extending private equity dealmaking in life sciences
Biotech By Kate Sheridan When biotech acquisitions spike, early-stage startups are prime targets, analysis shows
Hospitals By Tara Bannow Advocate Aurora-Atrium’s mammoth merger: Experts split on whether federal regulators will challenge the deal
Biotech By Allison DeAngelis A new biotech investment firm, headed by a pair of noteworthy VCs, seeks to ‘free the founders’
Business By Tara Bannow and Bob Herman Omicron squeezed hospitals more than health insurers in the first quarter
Biotech By Adam Feuerstein and Damian Garde Biogen board slashes CEO’s bonus as Aduhelm sales and overall business struggle
First Opinion By Michelle Proser How hospitals and health systems can help patients avoid medical debt
The Readout LOUD By Damian Garde, Meg Tirrell and Adam Feuerstein Listen: An ominous biotech deal, vaccines for kids, & ‘breakthrough’ devices
First Opinion By Alyssa Jaffee If there is a digital health bubble, does it really matter for entrepreneurs?
Health Tech By Mohana Ravindranath and Mario Aguilar Health tech companies strike deals to grow virtual diabetes care, telepsychiatry
Insurance By Bob Herman ‘Completely unsustainable’: Small employers brace for giant health insurance price hikes
Special Report By Tara Bannow Hospitals have been financially propping up medical schools, but now it’s squeezing their bottom lines
Opinions+ By Marc Herant and Jason Brauner Incentives to spur repurposing of existing generics for novel uses would open a new paradigm in drug R&D
Biotech By Kate Sheridan Private equity giant Carlyle to acquire biotech venture capital firm Abingworth